🔴 Noveris Health Sciences is trading 5% down today; no clear company-specific catalyst

Noveris Health Sciences is trading 5% down at CA$0.10, with no clear company-specific catalyst identified.

• No clear September 11, 2026 company-specific catalyst was identified.
• The September 9 meeting-results announcement said all shareholder resolutions were approved, including director elections, auditor appointment, incentive-plan approval, and quorum amendments.
• Broad U.S. markets are rising while Noveris moves lower; the decline cannot be confidently attributed to overall market sentiment. Trading volume and activity details were unavailable.